C2N Diagnostics

Health & Medical Electronics · Medical Laboratories
$35Mtotal raised · 4 rounds on record
$10Mlatest round · Venture round · May 2025 · 18 mo ago
$2Mgrants · 2 grants · CORDIS
50+team · employees, estimated range

Overview

Developing and accelerating novel diagnostics and therapies for Alzheimer’s disease. C2N new PrecivityAD™ blood test for Alzheimers disease.

Funding and backers

Total raised
$35M
4 rounds on record
Latest round
$10M
Venture round · May 2025 · 18 mo ago
Team
51-200
employees, estimated range
Grants
$2M
2 grants · CORDIS
The money's age
Due for its next round
18 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 12, 2025 Raised a round Venture round $10M · SEC Form D Mar 1, 2024 Raised a round Venture round $25M · SEC Form D May 15, 2019 Won a grant $1.7M · CORDIS May 15, 2018 Won a grant $224k · CORDIS
Funding rounds
RoundDateAmountInvestorsSource
Venture round May 2025 $10M — SEC Form D
Venture round Mar 2024 $25M — SEC Form D
Grant May 2019 $1.7M — CORDIS
Grant May 2018 $224k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity C2N Diagnostics, LLC SEC Form D
Founders and leadersfrom filings, registers and the company's site
Dr. Joel BraunsteinExecutive Officer, DirectorSEC Form D
Micah OnixtExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs Qvin, Examedi
Antler
backs Breathonix
Soma Capital
backs Qvin
VentureSouq
backs Qvin
RTP Global
backs Ahead Health
Blue Lion
backs Hemetron Logo
Similar startupsby what they do, their industry and backers
Ahead HealthVenture round $10M · 3 mo ago · 51-200 employees
Early detection of cancer, liver disease and over 500 other diseases. Receive a personal health action plan with full body MRI and blood…
Breathonix
Beyond delivering results faster than a blood test using breath testing.
Unravel Health
The only device that measures multiple hormones in saliva in near real time, revealing patterns blood tests miss. Transform how you…
Hemetron Logo
Hemetron develops the first at-home blood test that is accurate, quantitative and affordable.
Qvin
Qvin is the first and only healthcare service to scientifically prove menstrual blood can test for relevant health information - like a lab…
Savics
Savics offers digital solutions for health actors to improve their data management, disease diagnostics and GeneXpert connectivity.

Visa sponsorship

United StatesUS 0
0
H-1B filings in 12 months
0
Open roles in United States
In the register as C2N Diagnostics, LLC, St. Louis, MO
Other sponsors in the same field
Endless 3 filingsTruHearing 2 filingsAegis Sciences Corporation 1 filingsMatrix One 1 filings
Alert me
US Department of Labor · latest filing Jun 23, 2025 · Visa details by country

Financials

Total raised
$37M
Latest round
Venture - Series Unknown
Funding rounds
4
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $10M Details
Venture - Series Unknown 2024 $25M Details
Grant 2019 $1.7M Details
Grant 2018 $224k Details

People

Dr. Joel Braunstein
Executive Officer, Director
SEC Form D
Micah Onixt
Executive Officer
SEC Form D
Dr. Randall Bateman
Director
SEC Form D
Dr. Michael Goldblatt
Director
SEC Form D
Dr. David Holtzman
Director
SEC Form D
Fred Miller
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Saint Louis United States
HQ
C2N Diagnostics
50-200 est. staff
4340 Duncan Avenue, St. Louis, MO 63110
company site